Docetaxel With Cyclophosphamide Is Associated With an Overall Survival Benefit Compared With Doxorubicin and Cyclophosphamide: 7-Year Follow-Up of US Oncology Research Trial 9735 von JONES, Stephen, HOLMES, Frankie Ann, HYMAN, William J, RICHARDS, Donald A, MENNEL, Robert G, BOEHM, Kristi A, MEYER, Wally G, ASMAR, Lina, MACKEY, Daniel, RIEDEL, Stefan, MUSS, Hyman, SAVIN, Michael A, O'SHAUGHNESSY, Joyce, BLUM, Joanne L, VUKELJA, Svetislava J, MCINTYRE, Kristi J, PIPPEN, John E, BORDELON, James H, KIRBY, Robert L, SANDBACH, John

Volltext

Phase III Trial Comparing Doxorubicin Plus Cyclophosphamide With Docetaxel Plus Cyclophosphamide As Adjuvant Therapy for Operable Breast Cancer von JONES, Stephen E, SAVIN, Michael A, SANDBACH, John, HYMAN, William J, KHANDELWAL, Pankaj, NEGRON, Angel G, RICHARDS, Donald A, ANTHONY, Stephen P, MENNEL, Robert G, BOEHM, Kristi A, MEYER, Walter G, ASMAR, Lina, HOLMES, Frankie Ann, O'SHAUGHNESSY, Joyce A, BLUM, Joanne L, VUKELJA, Svetislava, MCINTYRE, Kristi J, PIPPEN, John E, BORDELON, James H, KIRBY, Robert

Volltext

Evaluation of Miracle Mouthwash plus Hydrocortisone Versus Prednisolone Mouth Rinses as Prophylaxis for Everolimus‐Associated Stomatitis: A Randomized Phase II Study von Jones, Vicky E., McIntyre, Kristi J., Paul, Devchand, Wilks, Sharon T., Ondreyco, Sharon M., Sedlacek, Scot, Melnyk, Anton, Oommen, Sanjay P., Wang, Yunfei, Peck, Susan R., O'Shaughnessy, Joyce A.

Volltext

Pathologic complete response after preoperative anti-HER2 therapy correlates with alterations in PTEN, FOXO, phosphorylated Stat5, and autophagy protein signaling von Holmes, Frankie Ann, Espina, Virginia, Liotta, Lance A, Nagarwala, Yasir M, Danso, Michael, McIntyre, Kristi J, Osborne, Cynthia R C, Anderson, Thomas, Krekow, Lea, Blum, Joanne L, Pippen, John, Florance, Allison, Mahoney, Janine, O'Shaughnessy, Joyce A

Volltext

Health-related quality of life in patients receiving first-line eribulin mesylate with or without trastuzumab for locally recurrent or metastatic breast cancer von Schwartzberg, Lee, McIntyre, Kristi, Wilks, Sharon, Puhalla, Shannon, O'Shaughnessy, Joyce, Berrak, Erhan, He, Yaohua, Vahdat, Linda

Volltext

Phase 2 study of eribulin mesylate as first-line therapy for locally recurrent or metastatic human epidermal growth factor receptor 2-negative breast cancer von McIntyre, Kristi, O’Shaughnessy, Joyce, Schwartzberg, Lee, Glück, Stefan, Berrak, Erhan, Song, James X., Cox, David, Vahdat, Linda T.

Volltext

Randomized phase-II evaluation of letrozole plus dasatinib in hormone receptor positive metastatic breast cancer patients von Paul, Devchand, Vukelja, Svetislava J., Ann Holmes, Frankie, Blum, Joanne L., McIntyre, Kristi J., Lindquist, Deborah L., Osborne, Cynthia R., Sanchez, Ines J., Goldschmidt, Jerome H., Wang, Yunfei, Asmar, Lina, Strauss, Lewis, O’Shaughnessy, Joyce

Volltext

Case Studies in the Management of Metastatic Breast Cancer with Eribulin von Wilks, Sharon, Mcintyre, Kristi

Volltext

Impact of prior anthracycline or taxane use on eribulin effectiveness as first-line treatment for metastatic breast cancer: results from two phase 2, multicenter, single-arm studie... von O’Shaughnessy, Joyce, McIntyre, Kristi, Schwartzberg, Lee, Wilks, Sharon, Puhalla, Shannon, Berrak, Erhan, Song, James, Vahdat, Linda

Volltext

Phase III Multicenter Trial of Doxorubicin Plus Cyclophosphamide Followed by Paclitaxel Compared With Doxorubicin Plus Paclitaxel Followed by Weekly Paclitaxel As Adjuvant Therapy... von LOESCH, David, GRECO, F. Anthony, PIPPEN, John, LINDQUIST, Deborah, MCINTYRE, Kristi, BLUM, Joanne L, MODIANO, Manuel R, BOEHM, Kristi A, FENG ZHAN, ASMAR, Lina, ROBERT, Nicholas, SENZER, Neil N, BURRIS, Howard A, HAINSWORTH, John D, JONES, Stephen, VUKELJA, Svetislava J, SANDBACH, John, HOLMES, Frankie, SEDLACEK, Scot

Volltext

Erratum to: Phase 2 study of eribulin mesylate as first-line therapy for locally recurrent or metastatic human epidermal growth factor receptor 2-negative breast cancer von McIntyre, Kristi, O’Shaughnessy, Joyce, Schwartzberg, Lee, Glück, Stefan, Berrak, Erhan, Song, James X., Cox, David, Vahdat, Linda T.

Volltext

Five‐year results of a phase II trial of preoperative 5‐fluorouracil, epirubicin, cyclophosphamide followed by docetaxel with capecitabine (wTX) (with trastuzumab in HER2‐positive... von Holmes, Frankie Ann, Hellerstedt, Beth A., Pippen, John E., Vukelja, Svetislava J., Collea, Rufus P., Kocs, Darren M., Blum, Joanne L., McIntyre, Kristi J., Barve, Minal A., Brooks, Barry D., Osborne, Cynthia R., Wang, Yunfei, Asmar, Lina, O'Shaughnessy, Joyce

Volltext

Results of a phase II study of pemetrexed as first-line chemotherapy in patients with advanced or metastatic breast cancer von Robert, Nicholas J, Conkling, Paul R, O'Rourke, Mark A, Kuefler, Paul R, McIntyre, Kristi J, Zhan, Feng, Asmar, Lina, Wang, Yanping, Shonukan, Oluwatoyin O, O'Shaughnessy, Joyce A

Volltext

Results of a phase II open-label, nonrandomized trial of oral satraplatin in patients with metastatic breast cancer von Smith, John W. II, McIntyre, Kristi J, Acevedo, Patrick V, Encarnacion, Carlos A, Tedesco, Karen L, Wang, Yunfei, Asmar, Lina, O'Shaughnessy, Joyce A

Volltext

Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA von Liu, M.C., Klein, E.A., Swanton, C., Seiden, M.V., Klein, Eric A., Yeatman, Timothy J., Cohn, Allen L., Lapham, Rosanna, Parker, Alexander S., McIntyre, Kristi, Sekeres, Mikkael A., Siegel, Robert, Wang, Xuezhong, Cosgrove, David P., Trent, Jonathan, Thiel, David D., Garbo, Lawrence E., Giguere, Jeffrey K., Michels, Ross M., Harris, Ronald P., Richey, Stephen L., McCarthy, Timothy A., Couch, Fergus J., Wilks, Sharon T., Krie, Amy K., Balaraman, Rama, Rieger-Christ, Kimberly, Sullivan, Travis, Greenwald, Daniel R., Oh, William, Tsao, Che-Kai, Kennecke, Hagen F., Manhas, Atisha P., Ulrich, Brian K., Kovoor, Philip A., Stokoe, Christopher, Courtright, Jay G., Larson, Timothy G., Seiden, Michael V., Cummings, Steven R., Absalan, Farnaz, Alexander, Gregory, Allen, Brian, Aravanis, Alexander M., Beausang, John F., Berman, Jennifer, Bredno, Joerg, Calef, Robert, Cann, Gordon, Carter, Jeremy, Chen, Xiaoji, Chien, Tom C., Davydov, Konstantin, Demas, Vasiliki, Fields, Alexander P., Freese, Peter, Gnerre, Sante, Gross, Samuel, Hall, Megan P., Hartman, Anne-Renee, Hou, Chenlu, Hubbell, Earl, Jiang, Roger, Kim, TaeHyung, Klausner, Richard D., Kurtzman, Kathryn N., Lee, Mark, Lin, Wendy, Lipson, Jafi, Maddala, Tara, Maher, M. Cyrus, Melton, Collin, Mich, Andrea, Newman, Joshua, Nicula, Virgil, Nikolic, Ongjen, Patel, Shilpen, Rava, Richard, Schellenberger, Jan, Scott, Eric, Sehnert, Amy J., Shaknovich, Rita, Shanmugam, Avinash, Shashidhar, K.C., Shenoy, Archana, Shojaee, Seyedmehdi, Tang, Susan, Valouev, Anton, Venn, Oliver, Williams, Richard T., Wu, Tony, Yakym, Christopher, Yang, Xiao, Yecies, Jessica, Yip, Alexander S., Yue, Jeanne, Zhang, Lily, Zhang, Lori (Quan), Curtis, Christina, Berry, Donald A.

Volltext

Addition of the PARP inhibitor veliparib plus carboplatin or carboplatin alone to standard neoadjuvant chemotherapy in triple-negative breast cancer (BrighTNess): a randomised, pha... von Loibl, Sibylle, O'Shaughnessy, Joyce, Untch, Michael, Sikov, William M, Rugo, Hope S, McKee, Mark D, Huober, Jens, Golshan, Mehra, von Minckwitz, Gunter, Maag, David, Sullivan, Danielle, Wolmark, Norman, McIntyre, Kristi, Ponce Lorenzo, Jose J, Metzger Filho, Otto, Rastogi, Priya, Symmans, W Fraser, Liu, Xuan, Geyer, Charles E

Volltext

Evaluation of cell-free DNA approaches for multi-cancer early detection von Jamshidi, Arash, Liu, Minetta C., Klein, Eric A., Venn, Oliver, Hubbell, Earl, Beausang, John F., Gross, Samuel, Melton, Collin, Fields, Alexander P., Liu, Qinwen, Zhang, Nan, Fung, Eric T., Kurtzman, Kathryn N., Amini, Hamed, Betts, Craig, Civello, Daniel, Freese, Peter, Calef, Robert, Davydov, Konstantin, Fayzullina, Saniya, Hou, Chenlu, Jiang, Roger, Jung, Byoungsok, Tang, Susan, Demas, Vasiliki, Newman, Joshua, Sakarya, Onur, Scott, Eric, Shenoy, Archana, Shojaee, Seyedmehdi, Steffen, Kristan K., Nicula, Virgil, Chien, Tom C., Bagaria, Siddhartha, Hunkapiller, Nathan, Desai, Mohini, Dong, Zhao, Richards, Donald A., Yeatman, Timothy J., Cohn, Allen L., Thiel, David D., Berry, Donald A., Tummala, Mohan K., McIntyre, Kristi, Sekeres, Mikkael A., Bryce, Alan, Aravanis, Alexander M., Seiden, Michael V., Swanton, Charles

Volltext

Comparative Efficacy and Safety of Adjuvant Letrozole Versus Anastrozole in Postmenopausal Patients With Hormone Receptor-Positive, Node-Positive Early Breast Cancer: Final Results... von Smith, Ian, Yardley, Denise, Burris, Howard, De Boer, Richard, Amadori, Dino, McIntyre, Kristi, Ejlertsen, Bent, Gnant, Michael, Jonat, Walter, Pritchard, Kathleen I, Dowsett, Mitch, Hart, Lowell, Poggio, Susan, Comarella, Lisa, Salomon, Herve, Wamil, Barbara, O'Shaughnessy, Joyce

Volltext

Preference for the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in patients with HER2-positive early breast cancer (PHranceSCa): A randomised, op... von O'Shaughnessy, Joyce, Sousa, Susana, Cruz, Josefina, Fallowfield, Lesley, Auvinen, Päivi, Pulido, Catarina, Cvetanovic, Ana, Wilks, Sharon, Ribeiro, Leonor, Burotto, Mauricio, Klingbiel, Dirk, Messeri, Dimitri, Alexandrou, Ari, Trask, Peter, Fredriksson, Judy, Machackova, Zuzana, Stamatovic, Ljiljana, Korbenfeld, Ernesto, Nadal, Jorge, Pinczowski, Helio, Cruz, Felipe J., Sousa, Gustavo, Goncalves, Aline C., Guilgen, Gisah, Burotto, Mauricio, Jekunen, Antti, Auvinen, Päivi, Yeo, Winne, Cheng, Chi K., Razeq, Hikmat A., Karak, Fadi, Farhat, Fadi, Huerta, Servando C., Jaime, Brizio M., Feregrino, Juan, Castillo-Fernandez, Omar, Alcedo, Juan C., Ribeiro, Leonor, Dionisio, Maria, Sousa, Susana, Pulido, Catarina, Bujassoum, Salha, Bakhraibah, Hatoon, Cvetanovic, Ana, Stamatovic, Ljiljana, Lescure, Alvaro R., Cruz, Josefina, Wendt, Camilla, Margolin, Sara, Björneklett, Helena G., Cairo, Michelina, Dakhil, Shaker, Le-Lindqwister, Nguyet, Ma, Ling, McIntyre, Kristi J., O’Shaughnessy, Joyce, Vukelja, Svetislava J., Richards, Donald, Wilks, Sharon, Wallmark, John

Volltext

Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial von Wenham, Robert M, Pickett, Cheryl A, Park, Sang Yoon, Makarova, Yulia, Krikunova, Ludmila, Bae, Duk-Soo, Zamagni, Claudio, Tognon, Germana, Ortega, Eugenia, Green, Andrew, Burger, Robert, Sanchez, Andres Redondo, Peen, Ulla, Kamelle, Scott, Carney, Michael, Forget, Frédéric, Bentley, James, Sehouli, Jalid, Kato, Hidenori, Shahin, Mark, Bhoola, Snehalkumar, Anderson, Daniel, Pelgrims, Joseph (Gino), Hansen, Vincent, Van den Bulck, Heidi, Yokota, Harushige, Friedman, Richard, Covens, Allan, Hilpert, Felix, Savarese, Antonella, Pignata, Sandro, Teneriello, Michael, Lentz, Samuel, Mannel, Robert, Lim, Peter, Zorr, Andreas, Karck, Ulrich, Aoki, Daisuke, Hirashima, Yasuyuki, Boere, Ingrid, Braly, Patricia, Schilder, Jeanne, Secord, Angeles, Rojas-Espaillat, Luis, Schauer, Christian, Joosens, Eric, Burges, Alexander, Park-Simon, Tjoung-Won, Alabiso, Oscar, Sawasaki, Takashi, Ibañez, Ana Herrero, Spillman, Monique, Moore, David, Verhoeven, Didier, Schnappauf, Benjamin, Schmalzrie, Hannah, Kalofonos, Haralambos, Diaz, Cristina Caballero, Polo, Susana Hernando, Garrison, Mitchell, Basil, Jack, Cosin, Jonathan, Wade III, James, Buekers, Thomas, DAndre, Stacy, Bakkum-Gamez, Jamie, Van Le, Linda, Puls, Larry, Michelson, Elizabeth Dickson, Kerger, Joseph, Heubner, Martin, Lordick, Florian, Villanueva, William Orlando Brito, Kessels, Lonneke, Fabregat, Miguel Beltran, Kumar, Pallavi, Karimi, Misagh, Edraki, Babak, Morris, Robert, Method, Michael, Drake, Janet, Wadsworth, Troy, Hurteau, Jean, Malad, Salman, Robinson-Bennett, Bernice, Davidson, Susan, Gaur, Rakesh, Krasner, Carolyn, Ueland, Frederick, Talmage, Lance, Sutton, Gregory, Osborne, Janet, Williams, James, Fleming, Nicole, Herzog, Thomas, Leitao, Mario, Mendez, Luis, Patel, Dhimant, Spitzer, Gary, Miller, Brigitte

Volltext